15
views
0
recommends
+1 Recommend
1 collections
    0
    shares
      • Record: found
      • Abstract: found
      • Article: found

      Growth Hormone Secretion Induced by Thyrotropin-Releasing Hormone in Adult Chickens: Evidence of Dose-Dependent Induction of either Refractoriness or Sensitization

      research-article
      a , b
      Neuroendocrinology
      S. Karger AG
      Growth hormone, Thyrotropin-releasing hormone

      Read this article at

      ScienceOpenPublisherPubMed
      Bookmark
          There is no author summary for this article yet. Authors can add summaries to their articles on ScienceOpen to make them more accessible to a non-specialist audience.

          Abstract

          Thyrotropin-releasing hormone (TRH) has been previously demonstrated to both stimulate growth hormone (GH) secretion and induce refractoriness to subsequent TRH provocation in vivo in chickens. Challenges with TRH at intervals of 1 h evoked different patterns of GH release in anesthetized adult chickens dependent upon TRH dosage. Initially, the administration of TRH at 10 µg/kg increased the plasma concentration of GH. However, the second and subsequent, through to the sixth challenges with TRH did not affect GH release. Plasma concentrations of GH were elevated by repeated injections of TRH (1.0 µg/kg). The magnitude of the response was reduced for the second and third challenges with full recovery of the GH response to the fifth challenge and an enhanced response to the sixth challenge. Similar GH secretory responses to TRH (at 0.1 µg/kg) were observed with the first through fourth challenge but the magnitude of response was again increased for the fifth and sixth challenge. At a lower dose (0.01 µg/kg), TRH did not initially affect plasma concentrations of GH. However, GH release was increased by the third challenge, and subsequent TRH administration evoked progressively larger increases in plasma concentration of GH. It would appear that only high doses of TRH induce refractoriness to subsequent challenge, while lower doses presensitize the pituitary to TRH. If TRH challenges at a dose which provokes the complete refractoriness (10 µg/kg) are administered at intervals of 2, 3 or 4 h, the GH secretory response is consistent for each challenge. The refractoriness to TRH is thus overcome within a period of 2 h.

          Related collections

          Author and article information

          Journal
          NEN
          Neuroendocrinology
          10.1159/issn.0028-3835
          Neuroendocrinology
          S. Karger AG
          0028-3835
          1423-0194
          1988
          1988
          02 April 2008
          : 47
          : 5
          : 369-373
          Affiliations
          aDepartment of Animal Science, Rutgers-The State University, New Brunswick, N.J., USA; bDepartment of Physiology, University of Alberta, Edmonton, Alta., Canada
          Article
          124940 Neuroendocrinology 1988;47:369–373
          10.1159/000124940
          3135504
          bef61195-d93e-4707-8a84-b7966b132992
          © 1988 S. Karger AG, Basel

          Copyright: All rights reserved. No part of this publication may be translated into other languages, reproduced or utilized in any form or by any means, electronic or mechanical, including photocopying, recording, microcopying, or by any information storage and retrieval system, without permission in writing from the publisher. Drug Dosage: The authors and the publisher have exerted every effort to ensure that drug selection and dosage set forth in this text are in accord with current recommendations and practice at the time of publication. However, in view of ongoing research, changes in government regulations, and the constant flow of information relating to drug therapy and drug reactions, the reader is urged to check the package insert for each drug for any changes in indications and dosage and for added warnings and precautions. This is particularly important when the recommended agent is a new and/or infrequently employed drug. Disclaimer: The statements, opinions and data contained in this publication are solely those of the individual authors and contributors and not of the publishers and the editor(s). The appearance of advertisements or/and product references in the publication is not a warranty, endorsement, or approval of the products or services advertised or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements.

          History
          : 11 May 1987
          : 31 August 1987
          Page count
          Pages: 5
          Categories
          Original Paper

          Endocrinology & Diabetes,Neurology,Nutrition & Dietetics,Sexual medicine,Internal medicine,Pharmacology & Pharmaceutical medicine
          Growth hormone,Thyrotropin-releasing hormone

          Comments

          Comment on this article